Comparative Cost Efficiency of the Originator Drug of Infliximab and its Biosimilar for the Treatment of Rheumatoid Arthritis in the MENA Region

Almaaytah, A; Elhajji, FD

Almaaytah, A (reprint author), Jordan Univ Sci & Technol, Dept Pharmaceut Technol, Fac Pharm, Irbid 21110, Jordan.

INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2019; 9 (1): 12

Abstract

Objectives: To study and assess the comparative cost efficiency of Infliximab's originator (Remicade (R)) and its biosimilar (Remsima (R)) in the trea......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索